GSK4418959
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK4418959, covering 2026-02-02 to 2026-02-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors [Phase 1, Phase 2]